You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / BLISS GVS PHARMA

BLISS GVS PHARMA
Intrinsic Value | Fundamental Analysis

Returns | 1W : 4.7% , 1M : -6.3%,1Y : -1.8%
BOM : 506197     NSE : BLISSGVS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Apr 22,2021
Price(EOD): Rs. 100.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 1,037.70 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
BLISS GVS PHARMA 4.7% -6.3% -1.8%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 11.4% 36.3%
DR REDDYS LABORATORIES 7.4% 23.5% 34.1%
DIVIS LABORATORIES -0.8% 14.8% 61.7%
CIPLA 3.3% 25.1% 62.3%
BIOCON -1.2% 2.6% 12.1%
AUROBINDO PHARMA 8.6% 23.1% 82.7%
LUPIN 1.1% 6.1% 34.7%
TORRENT PHARMACEUTICALS 0.4% 8.8% 11.6%

FUNDAMENTAL ANALYSIS OF BLISS GVS PHARMA

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than BLISS GVS PHARMA Premium


VALUATION OF BLISS GVS PHARMA

 
Valuation Score
RatioValue
P/E
P/B
P/S
10.67
P/E Calculated based on EPS of 9.43
[ Mar2020 - Consolidated Results ]

1.41
P/B Calculated based on Book Value of 71.32
[ Mar2020 - Consolidated Results ]

1.89
P/S Calculated based on Revenues of 548.744 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than BLISS GVS PHARMA Premium


FAIR VALUE OF BLISS GVS PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
52%
-12%
-12%

SHARE PRICE MOMENTUM OF BLISS GVS PHARMA

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.13
0.12
0.17
0.14
0.16
0.16
0.22
0.18
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0.33 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
8.26%
22.02%
23.41%
27.52%
10.97%
10.23%
7.78%
8.28%
QtrlyTrend
8
Latest Qtr: Dec2020

BLISS GVS PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.7% 15.3% 56.9%
S&P BSE SMALL CAP 0.5% 2.5% 90.8%
S&P BSE MIDSMALLCAP 0.2% 1.7% 80%
S&P BSE 400 MIDSMALLCAP 0% 1% 81%
S&P BSE 250 SMALLCAP -0.2% 0.1% 87.8%
S&P BSE ALLCAP -0.8% -0.3% 59.7%
S&P BSE 500 -0.9% -0.4% 58.8%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 0.3% 1% 90.9%
NIFTY MID SMALL400 -0.1% 0.9% 80.8%
NIFTY 500 -0.9% -0.4% 58.3%

FAQ [Frequently Asked Questions]


Is BLISSGVS good for long term investment?

As on 22-Apr-2021, the Fundamentals of BLISSGVS are Strong and hence it's good for long term investment! See Financial Performance of BLISS GVS PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BLISSGVS UnderValued or OverValued?

As on 22-Apr-2021, BLISSGVS is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of BLISSGVS ?

As on 22-Apr-2021, the Intrinsic Value of BLISSGVS is Rs. 114.43 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 66.21
Fair Value [Median EV / Sales Model] : Rs. 114.67
Fair Value [Median Price / Sales Model] : Rs. 114.43
Median Fair Value of BLISSGVS : Rs. 114.43

Is BLISSGVS trading at a Premium or Discount?

As on 22-Apr-2021, BLISSGVS is trading at a Discount of -12% based on the Median Intrinsic Value!

Is it right time to buy BLISSGVS shares?

As on 22-Apr-2021, BLISSGVS is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Financial Performance of Industry Peers of BLISSGVS?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with BLISSGVS?

BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
BLISS GVS PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z